SCHEMBL7879205

SCHEMBL7879205

NC(=O)c1csc(NC(=O)[CH]CCCCNC(=O)CC2CCCC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.38
KEAP1 Q14145 3/20 0.36
NFE2L2 Q16236 3/20 0.36
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPC1 O15118 3/20 0.34
RAB9A P51151 2/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
RECQL P46063 1/20 0.34
FPR3 P25089 1/20 0.34
FPR2 P25090 1/20 0.34
GLS O94925 1/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874778 0.75 HDAC3 (0.48) EPHX2SMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL7868172 0.74 HPGD (0.42) EPHX2KEAP1NFE2L2HPGDSMN1; SMN2
SCHEMBL7868121 0.73 MAPK1 (0.50) KEAP1NFE2L2SMN1; SMN2HDAC3HDAC4
SCHEMBL5057159 0.72 MAPK1 (0.39) SMN1; SMN2NPC1RAB9AGAAHDAC3
SCHEMBL7868159 0.70 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1RAB9A
SCHEMBL7868065 0.70 MAPK1 (0.48) KEAP1NFE2L2SMN1; SMN2HDAC3HDAC4
SCHEMBL5240059 0.68 EPHX2 (0.44) EPHX2HPGDSMN1; SMN2TP53KDM4E
SCHEMBL6056911 0.67 PDE5A (0.46) EPHX2SMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL15680573 0.67 KEAP1 (0.66) EPHX2KEAP1NFE2L2HPGDSMN1; SMN2
SCHEMBL7879229 0.66 PIN1 (0.43) HPGDSMN1; SMN2ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed